Below are references to the Guidelines used to create the corresponding tables in the trimming manuscripts.
EMEA
Note for Guidance on Carcinogenic Potential CPMP/SWP/2877/00
London, 25 July 2002
European Agency for the Evaluation of Medicinal Products
Evaluation of Medicines for Human Use
Committee for Proprietary Medicinal Products (CPMP) http://www.emea.europa.eu/pdfs/human/swp/287700en.pdf
Japanese Ministry of Health and Welfare (1997). Pharmaceuticals and Medical Safety Bureau. In: Guidelines for Toxicity Studies and Drugs. Yakuji Nippo, Tokyo, pp 147175
OECD. 1981. Test Guideline 451. Carcinogenicity Studies. In: OECD Guideline for the Testing of Chemicals. Organization for Economic Cooperation & Development, Paris
OECD. 1981. Test Guideline 452. Chronic Toxicity Studies. In: OECD Guideline for the Testing of Chemicals. Organization for Economic Cooperation & Development, Paris
OECD. 1981. Test Guideline 453. Combined Chronic Toxicity / Carcinogenicity Studies. In: OECD Guideline for the Testing of Chemicals. Organization for Economic Cooperation & Development, Paris
STP
Bregman CL, Adler RR, Morton DG, Regan KS, Yano BL; Society of Toxicologic Pathology (2003) Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP). Toxicol Pathol31: 252253. PubMed abstract
see also the comment:
Jacobs A, El Hage J, Hastings K, Jacobson-Kram D, Leighton J, Morse D (2003) Recommended tissue list for histopathologic examination. Toxicol Pathol31: 571
Further references
Leblanc B (2000) Pathology and tissue sampling protocols for rodent carcinogenicity studies: time for revision. Toxicol Pathol28: 628633
Ekman L (1998) The international harmonisation of guidelines in the future: a viewpoint from the industry. Toxicol Lett102-103: 551555